The logic of TGFβ signaling

FEBS Letters

Volumn 580, Issue 12, 2006, Pages 2811-2820

  Massagué, Joan ^a   Gomis, Roger R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Cancer; Cell cycle; Cyclin dependent kinase; Cytostasis; Metastasis; Receptor serine threonine kinase; Smad transcription factor; TGF ; Tumor suppressor

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; CYTOKINE; MEMBRANE RECEPTOR; PROTEIN KINASE (CALCIUM,CALMODULIN) II; PROTEIN SERINE THREONINE KINASE; SIGNAL PEPTIDE; SMAD PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXO; TRANSFORMING GROWTH FACTOR BETA;

CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CELL CYCLE ARREST; CELL FATE; CYTOSTASIS; DRUG INHIBITION; GENE ACTIVATION; GENE REPRESSION; GENOME ANALYSIS; HUMAN; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; SHORT SURVEY; SIGNAL TRANSDUCTION; TRANSCRIPTOMICS; ANIMAL; GENETIC TRANSCRIPTION; METABOLISM; REVIEW;

ANIMALS; HUMANS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 33646562542     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.04.033     Document Type: Short Survey

References (108)

1. Roberts A.B., and Sporn M.B. The transforming growth factor-betas. In: Roberts A.B. (Ed). Peptide Growth Factors and Their Receptors (1990), Springer-Verlag, Heidelberg 419-472
2. Massague J. The transforming growth factor-beta family. Annu. Rev. Cell Biol. 6 (1990) 597-641
3. Massague J. TGF-beta signal transduction. Annu. Rev. Biochem. 67 (1998) 753-791
4. Cheifetz S., Weatherbee J.A., Tsang M.L., Anderson J.K., Mole J.E., Lucas R., and Massague J. The transforming growth factor-beta system, a complex pattern of cross-reactive ligands and receptors. Cell 48 3 (1987) 409-415
5. Wrana J.L., Attisano L., Carcamo J., Zentella A., Doody J., Laiho M., Wang X.F., and Massague J. TGF beta signals through a heteromeric protein kinase receptor complex. Cell 71 6 (1992) 1003-1014
6. Laiho M., DeCaprio J.A., Ludlow J.W., Livingston D.M., and Massague J. Growth inhibition by TGF-beta linked to suppression of retinoblastoma protein phosphorylation. Cell 62 1 (1990) 175-185
7. Tsuchida K., Lewis K.A., Mathews L.S., and Vale W.W. Molecular characterization of rat transforming growth factor-beta type II receptor. Biochem. Biophys. Res. Commun. 191 3 (1993) 790-795
8. Takumi T., Moustakas A., Lin H.Y., and Lodish H.F. Molecular characterization of a type I serine-threonine kinase receptor for TGF-beta and activin in the rat pituitary tumor cell line GH3. Exp. Cell. Res. 216 1 (1995) 208-214
9. Attisano L., Wrana J.L., Cheifetz S., and Massague J. Novel activin receptors: distinct genes and alternative mRNA splicing generate a repertoire of serine/threonine kinase receptors. Cell 68 1 (1992) 97-108
10. Wrana J.L., Attisano L., Wieser R., Ventura F., and Massague J. Mechanism of activation of the TGF-beta receptor. Nature 370 6488 (1994) 341-347
11. Huse M., Chen Y.G., Massague J., and Kuriyan J. Crystal structure of the cytoplasmic domain of the type I TGF beta receptor in complex with FKBP12. Cell 96 3 (1999) 425-436
12. Huse M., Muir T.W., Xu L., Chen Y.G., Kuriyan J., and Massague J. The TGF beta receptor activation process: an inhibitor- to substrate-binding switch. Mol. Cell 8 3 (2001) 671-682
13. Chen H.B., Rud J.G., Lin K., and Xu L. Nuclear targeting of transforming growth factor-beta-activated Smad complexes. J. Biol. Chem. 280 22 (2005) 21329-21336
14. Xu L., Alarcon C., Col S., and Massague J. Distinct domain utilization by Smad3 and Smad4 for nucleoporin interaction and nuclear import. J. Biol. Chem. 278 43 (2003) 42569-42577
15. Liu F., Hata A., Baker J.C., Doody J., Carcamo J., Harland R.M., and Massague J. A human Mad protein acting as a BMP-regulated transcriptional activator. Nature 381 6583 (1996) 620-623
16. Kretzschmar M., Liu F., Hata A., Doody J., and Massague J. The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase. Genes. Dev. 11 8 (1997) 984-995
17. Hoodless P.A., Haerry T., Abdollah S., Stapleton M., O'Connor M.B., Attisano L., and Wrana J.L. MADR1, a MAD-related protein that functions in BMP2 signaling pathways. Cell 85 4 (1996) 489-500
18. Wu G., Chen Y.G., Ozdamar B., Gyuricza C.A., Chong P.A., Wrana J.L., Massague J., and Shi Y. Structural basis of Smad2 recognition by the Smad anchor for receptor activation. Science 287 5450 (2000) 92-97
19. Wu J.W., et al. Crystal structure of a phosphorylated Smad2. Recognition of phosphoserine by the MH2 domain and insights on Smad function in TGF-beta signaling. Mol. Cell 8 6 (2001) 1277-1289
20. Lagna G., Hata A., Hemmati-Brivanlou A., and Massagué J. Partnership between DPC4 and SMAD proteins in TGFβ signalling pathways. Nature 383 (1996) 832-836
21. Shi Y., and Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113 6 (2003) 685-700
22. Shi Y., Wang Y.-F., Jayaraman L., Yang H., Massagué J., and Pavletich N. Crystal structure of a Smad MH1 domain bound to DNA: insights on DNA-binding in TGF-β signaling. Cell 94 (1998) 585-594
23. Xu L., Kang Y., Col S., and Massague J. Smad2 nucleocytoplasmic shuttling by nucleoporins CAN/Nup214 and Nup153 feeds TGFbeta signaling complexes in the cytoplasm and nucleus. Mol. Cell 10 2 (2002) 271-282
24. Inman G.J., Nicolas F.J., and Hill C.S. Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGF-beta receptor activity. Mol. Cell 10 2 (2002) 283-294
25. Chen H.B., Shen J., Ip Y.T., and Xu L. Identification of phosphatases for Smad in the BMP/DPP pathway. Genes. Dev. (2006)
26. M. Knockaert, G. Sapkota, C. Alarcon, J. Massague and A.H. Brivanlou, New players in the BMP pathway: small CTD phosphatases dephophorylate Smad1 to attenuate BMP signaling (submitted for publication).
27. Ogunjimi A.A., et al. Regulation of Smurf2 ubiquitin ligase activity by anchoring the E2 to the HECT domain. Mol. Cell 19 3 (2005) 297-308
28. Lo R.S., and Massague J. Ubiquitin-dependent degradation of TGF-beta-activated smad2. Nat. Cell Biol. 1 8 (1999) 472-478
29. Massague J., and Chen Y.G. Controlling TGF-beta signaling. Genes. Dev. 14 6 (2000) 627-644
30. Massague J., Seoane J., and Wotton D. Smad transcription factors. Genes. Dev. 19 (2005) 2783-2810
31. Sirard C., et al. The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo. Genes. Dev. 12 1 (1998) 107-119
32. Subramanian G., Schwarz R.E., Higgins L., McEnroe G., Chakravarty S., Dugar S., and Reiss M. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1. Cancer Res. 64 15 (2004) 5200-5211
33. Wisotzkey R.G., Mehra A., Sutherland D.J., Dobens L.L., Liu X., Dohrmann C., Attisano L., and Raftery L.A. Medea is a Drosophila Smad4 homolog that is differentially required to potentiate DPP responses. Development 125 8 (1998) 1433-1445
34. He, W., Dorn, D.C., Erdjument-Bromage, H., Tempst, P., Moore, M.A.S. and Massague, J. Hematopoiesis controlled by distinct TIF1ã and Smad4 branches of the TGFâ Pathway, Cell (in press).
35. Derynck R., and Zhang Y.E. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425 6958 (2003) 577-584
36. Ozdamar B., Bose R., Barrios-Rodiles M., Wang H.R., Zhang Y., and Wrana J.L. Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity. Science 307 5715 (2005) 1603-1609
37. Foletta V.C., et al. Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1. J. Cell Biol. 162 6 (2003) 1089-1098
38. Lee-Hoeflich S.T., Causing C.G., Podkowa M., Zhao X., Wrana J.L., and Attisano L. Activation of LIMK1 by binding to the BMP receptor, BMPRII, regulates BMP-dependent dendritogenesis. Embo. J. 23 24 (2004) 4792-4801
39. Massague J. How cells read TGF-beta signals. Nat. Rev. Mol. Cell Biol. 1 3 (2000) 169-178
40. Feng X.H., and Derynck R. Specificity and selectivity in TGF-beta signaling through Smads. Annu. Rev. Cell Dev. Biol. 21 (2005) 659-666
41. Zawel L., Dai J.L., Buckhaults P., Zhou S., Kinzler K.W., Vogelstein B., and Kern S.E. Human Smad3 and Smad4 are sequence-specific transcription activators. Mol. Cell 1 4 (1998) 611-617
42. Kim J., Johnson K., Chen H.J., Carroll S., and Laughon A. Drosophila Mad binds to DNA and directly mediates activation of vestigial by Decapentaplegic. Nature 388 (1997) 304-308
43. Chen C.R., Kang Y., Siegel P.M., and Massague J. E2F4/5 and p107 as Smad cofactors linking the TGFbeta receptor to c-myc repression. Cell 110 1 (2002) 19-32
44. Chen X., Rubock M.J., and Whitman M. A transcriptional partner for MAD proteins in TGF-b signalling. Nature 383 (1996) 691-696
45. Kang Y., Chen C.R., and Massague J. A self-enabling TGFbeta response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. Mol. Cell 11 4 (2003) 915-926
46. Chen C.R., Kang Y., and Massague J. Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor beta growth arrest program. Proc. Natl. Acad. Sci. USA 98 3 (2001) 992-999
47. Zavadil J., Bitzer M., Liang D., Yang Y.C., Massimi A., Kneitz S., Piek E., and Bottinger E.P. Genetic programs of epithelial cell plasticity directed by transforming growth factor-beta. Proc. Natl. Acad. Sci. USA 98 12 (2001) 6686-6691
48. Niehrs C., and Pollet N. Synexpression groups in eukaryotes. Nature 402 6761 (1999) 483-487
49. Gomis, R.R., Alarcon, C., Nadal, C., He, W., Wang, Q., Seoane, J., Van Poznak, C., Massague, J. C/EBPbeta at the core of the TGF cytostatic response and its evasion in metastatic breast cancers (submitted for publication).
50. Accili D., and Arden K.C. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation,. Cell 117 4 (2004) 421-426
51. Tran H., Brunet A., Griffith E.C., and Greenberg M.E. The many forks in FOXO's road. Sci. STKE 2003 172 (2003) RE5
52. Seoane J., Le H.V., Shen L., Anderson S.A., and Massague J. Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell 117 2 (2004) 211-223
53. McKnight S.L. McBindall - a better name for CCAAT/enhancer binding proteins?. Cell 107 (2001) 259-261
54. Grimm S.L., and Rosen J.M. The role of C/EBPbeta in mammary gland development and breast cancer. J. Mammary Gland Biol. Neoplasia. 8 2 (2003) 191-204
55. Begay V., Smink J., and Leutz A. Essential requirement of CCAAT/enhancer binding proteins in embryogenesis. Mol. Cell Biol. 24 22 (2004) 9744-9751
56. Massague J. Integration of Smad and MAPK pathways: a link and a linker revisited. Genes. Dev. 17 (2003) 2993-2997
57. Kretzschmar M., Doody J., and Massagué J. Opposing BMP and EGF signalling pathway converge on the TGFβ family mediator Smad1. Nature 389 (1997) 618-622
58. Kretzschmar M., Doody J., Timokhina I., and Massague J. A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras. Genes. Dev. 13 7 (1999) 804-816
59. Wicks S.J., Lui S., Abdel-Wahab N., Mason R.M., and Chantry A. Inactivation of smad-transforming growth factor beta signaling by Ca(2+)-calmodulin-dependent protein kinase II. Mol. Cell Biol. 20 21 (2000) 8103-8111
60. Matsuura I., Denissova N.G., Wang G., He D., Long J., and Liu F. Cyclin-dependent kinases regulate the antiproliferative function of Smads. Nature 430 6996 (2004) 226-231
61. Grimm O.H., and Gurdon J.B. Nuclear exclusion of Smad2 is a mechanism leading to loss of competence. Nat. Cell Biol. 4 7 (2002) 519-522
62. Pera E.M., Ikeda A., Eivers E., and De Robertis E.M. Integration of IGF, FGF, and anti-BMP signals via Smad1 phosphorylation in neural induction. Genes. Dev. 17 24 (2003) 3023-3028
63. Hu M.C., et al. IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 117 2 (2004) 225-237
64. Brunet A., et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303 5666 (2004) 2011-2015
65. Motta M.C., Divecha N., Lemieux M., Kamel C., Chen D., Gu W., Bultsma Y., McBurney M., and Guarente L. Mammalian SIRT1 represses forkhead transcription factors. Cell 116 4 (2004) 551-563
66. Koff A., Ohtsuki M., Polyak K., Roberts J.M., and Massague J. Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta. Science 260 5107 (1993) 536-539
67. Datto M.B., Li Y., Panus J.F., Howe D.J., Xiong Y., and Wang X.F. Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl. Acad. Sci. USA 92 12 (1995) 5545-5549
68. Hannon G.J., and Beach D. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 371 6494 (1994) 257-261
69. Alexandrow M.G., and Moses H.L. Transforming growth factor β and cell cycle regulation. Cancer Res. 55 (1995) 1452-1457
70. Scandura J.M., Boccuni P., Massague J., and Nimer S.D. Transforming growth factor beta-induced cell cycle arrest of human hematopoietic cells requires p57KIP2 up-regulation. Proc. Natl. Acad. Sci. USA. 101 (2004) 15231-15236
71. Polyak K., Kato J.Y., Solomon M.J., Sherr C.J., Massague J., Roberts J.M., and Koff A. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes. Dev. 8 1 (1994) 9-22
72. Polyak K., Lee M.H., Erdjument-Bromage H., Koff A., Roberts J.M., Tempst P., and Massague J. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78 1 (1994) 59-66
73. Reynisdottir I., Polyak K., Iavarone A., and Massague J. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes. Dev. 9 15 (1995) 1831-1845
74. Staller P., et al. Repression of p15INK4b expression by Myc through association with Miz-1. Nat. Cell Biol. 3 4 (2001) 392-399
75. Seoane J., Pouponnot C., Staller P., Schader M., Eilers M., and Massague J. TGFbeta influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b. Nat. Cell Biol. 3 4 (2001) 400-408
76. Seoane J., Le H.V., and Massague J. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature 419 6908 (2002) 729-734
77. Massague J., Blain S.W., and Lo R.S. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 103 2 (2000) 295-309
78. Markowitz S., et al. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268 5215 (1995) 1336-1338
79. Izumoto S., Arita N., Ohnishi T., Hiraga S., Taki T., Tomita N., Ohue M., and Hayakawa T. Microsatellite instability and mutated type II transforming growth factor-beta receptor gene in gliomas. Cancer Lett. 112 2 (1997) 251-256
80. Grady W.M., et al. Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers. Cancer Res. 59 2 (1999) 320-324
81. Chen T., Carter D., Garrigue-Antar L., and Reiss M. Transforming growth factor beta type I receptor kinase mutant associated with metastatic breast cancer. Cancer Res. 58 21 (1998) 4805-4810
82. Goggins M., Shekher M., Turnacioglu K., Yeo C.J., Hruban R.H., and Kern S.E. Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas. Cancer Res. 58 23 (1998) 5329-5332
83. Wang D., Kanuma T., Mizunuma H., Takama F., Ibuki Y., Wake N., Mogi A., Shitara Y., and Takenoshita S. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer. Cancer Res. 60 16 (2000) 4507-4512
84. Howe J.R., Bair J.L., Sayed M.G., Anderson M.E., Mitros F.A., Petersen G.M., Velculescu V.E., Traverso G., and Vogelstein B. Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat. Genet. 28 2 (2001) 184-187
85. Derynck R., Akhurst R.J., and Balmain A. TGF-beta signaling in tumor suppression and cancer progression. Nat. Genet. 29 2 (2001) 117-129
86. Roberts A.B., and Wakefield L.M. The two faces of transforming growth factor beta in carcinogenesis. Proc. Natl. Acad. Sci. USA 100 15 (2003) 8621-8623
87. Siegel P.M., and Massague J. Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat. Rev. Cancer 3 11 (2003) 807-821
88. Bhowmick N.A., Chytil A., Plieth D., Gorska A.E., Dumont N., Shappell S., Washington M.K., Neilson E.G., and Moses H.L. TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 303 5659 (2004) 848-851
89. Cui W., Fowlis D.J., Bryson S., Duffie E., Ireland H., Balmain A., and Akhurst R.J. TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 86 4 (1996) 531-542
90. Jennings M.T., and Pietenpol J.A. The role of transforming growth factor beta in glioma progression. J. Neurooncol. 36 2 (1998) 123-140
91. Anbazhagan R., Fujii H., and Gabrielson E. Microsatellite instability is uncommon in breast cancer. Clin. Cancer Res. 5 4 (1999) 839-844
92. Gold L.I. The role for transforming growth factor-beta (TGF-beta) in human cancer. Crit. Rev. Oncog. 10 4 (1999) 303-360
93. Gorelik L., and Flavell R.A. Transforming growth factor-beta in T-cell biology. Nat. Rev. Immunol. 2 1 (2002) 46-53
94. Thomas D.A., and Massague J. TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance. Cancer Cell 8 5 (2005) 369-380
95. Wojtowicz-Praga S. Reversal of tumor-induced immunosuppression by TGF-beta inhibitors. Invest. New Drugs 21 1 (2003) 21-32
96. Kang Y., et al. Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway. Proc. Natl. Acad. Sci. USA 102 39 (2005) 13909-13914
97. Dumont N., and Arteaga C.L. Targeting the TGF beta signaling network in human neoplasia. Cancer Cell 3 6 (2003) 531-536
98. Herrera R.E., Makela T.P., and Weinberg R.A. TGF beta-induced growth inhibition in primary fibroblasts requires the retinoblastoma protein. Mol. Biol. Cell 7 (1996) 1335-1342
99. Latres E., Malumbres M., Sotillo R., Martin J., Ortega S., Martin-Caballero J., Flores J.M., Cordon-Cardo C., and Barbacid M. Limited overlapping roles of P15(INK4b) and P18(INK4c) cell cycle inhibitors in proliferation and tumorigenesis. EMBO J. 19 (2000) 3496-3506
100. Holland E.C. Gliomagenesis: genetic alterations and mouse models. Nat. Rev. Genet. 2 2 (2001) 120-129
101. Xuan S., Baptista C.A., Balas G., Tao W., Soares V.C., and Lai E. Winged helix transcription factor BF-1 is essential for the development of the cerebral hemispheres. Neuron 14 6 (1995) 1141-1152
102. Hanashima C., Shen L., Li S.C., and Lai E. Brain factor-1 controls the proliferation and differentiation of neocortical progenitor cells through independent mechanisms. J. Neurosci. 22 15 (2002) 6526-6536
103. Hanashima C., Li S.C., Shen L., Lai E., and Fishell G. Foxg1 suppresses early cortical cell fate. Science 303 5654 (2004) 56-59
104. Rich J.N. The role of transforming growth factor-beta in primary brain tumors. Front Biosci. 8 (2003) e245-e260
105. Kang Y., Siegel P.M., Shu W., Drobnjak M., Kakonen S.M., Cordon-Cardo C., Guise T.A., and Massague J. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3 6 (2003) 537-549
106. Diebold R.J., Eis M.J., Yin M., Ormsby I., Boivin G.P., Darrow B.J., Saffitz J.E., and Doetschman T. Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated. Proc. Natl. Acad. Sci. USA 92 26 (1995) 12215-12219
107. Siegel P.M., Shu W., Cardiff R.D., Muller W.J., and Massague J. Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis. Proc. Natl. Acad. Sci. USA 100 14 (2003) 8430-8435
108. Yin J.J., Selander K., Chirgwin J.M., Dallas M., Grubbs B.G., Wieser R., Massague J., Mundy G.R., and Guise T.A. TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J. Clin. Invest. 103 2 (1999) 197-206